Mast cells and canine mast cell tumours. A review
Author:
Open Access
- 1 December 2004
- journal article
- review article
- Published by Taylor & Francis in Veterinary Quarterly
- Vol. 26 (4) , 156-169
Abstract
This article reviews the literature on mast cells and tumours derived from mast cells in the dog. Mast cells play a central role in inflammatory and inunune reactions. Mast cells, normal and neoplastic, contain and release important biologically active substances: heparin, histamine, eosinophilic chemotactic factor and proteolytic enzymes. Mast cell tumours occur in the dog, particularly in the boxer and related breeds, in the skin and less frequently in the intestines. Cytology usually provides an accurate diagnosis, but histological examination adds further information concerning the histologic grade and the completeness of surgical therapy. Cutaneous mast cell tumours should be regarded as potentially malignant and therefore be removed widely (3 cm. margin). Local recurrence, regional and distant metastases together with paraneoplastic disorders may cause the death of the pet. Histologic grading (2 or 3 grades) and clinical staging together with kinetic parameters and breed (boxers have relatively benign tumours) are important prognostic parameters. Based on prognostic criteria, surgical treatment should be completed with adjuvant radiotherapy, corticosteroids and eventually with combined chemotherapy. A novel, promising therapy is the application of the receptor kinase inhibitor. The study of the pathogenesis of mast cell tumours received new impetus by the finding of mutations, deletions and duplications, in exons 11 and 12 of the C‐kit oncogene. Further study of physiological and oncological aspects of mast cells are favoured by the availability of mast cells isolated from spontaneous mast cell tumours and of cultured cell lines.Keywords
This publication has 74 references indexed in Scilit:
- RESULTS OF RADIATION THERAPY IN 19 DOGS WITH CUTANEOUS MAST CELL TUMOR AND REGIONAL LYMPH NODE METASTASISVeterinary Radiology & Ultrasound, 2002
- Evaluation of cell-surface IgE receptors on the canine mastocytoma cell line C2 maintained in continuous cultureAmerican Journal of Veterinary Research, 2002
- Peritoneal Effusion in a Dog Secondary to Visceral Mast Cell TumorActa Cytologica, 2001
- Splenic mast cell tumour and mastocytaemia in a cat: case study and literature reviewNew Zealand Veterinary Journal, 2000
- A Prospective Study of Radiation Therapy for the Treatment of Grade 2 Mast Cell Tumors in 32 DogsJournal of Veterinary Internal Medicine, 1996
- Correlation of DNA Ploidy to Tumor Histologic Grade, Clinical Variables, and Survival in Dogs with Mast Cell TumorsVeterinary Pathology, 1992
- Conjugated Avidin-peroxidase as a Stain for Mast Cell TumorsVeterinary Pathology, 1988
- Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining.Journal of Histochemistry & Cytochemistry, 1988
- Response of Canine Mast Cell Tumors to Radiation2JNCI: Journal of the National Cancer Institute, 1979
- The prognosis following surgical removal of mastocytomas in dogsJournal of Small Animal Practice, 1973